[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 49, "title": "Co-Founder, CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 570781, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 53, "title": "Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 358981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 367467, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 60, "title": "Co-Founder, Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.3614, "open": 4.3, "dayLow": 4.12, "dayHigh": 4.46, "regularMarketPreviousClose": 4.3614, "regularMarketOpen": 4.3, "regularMarketDayLow": 4.15, "regularMarketDayHigh": 4.46, "payoutRatio": 0.0, "beta": -0.861, "forwardPE": -0.5745554, "volume": 66615, "regularMarketVolume": 66615, "averageVolume": 146979, "averageVolume10days": 115370, "averageDailyVolume10Day": 115370, "bid": 4.16, "ask": 4.33, "bidSize": 1, "askSize": 1, "marketCap": 17831982, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 20.83, "fiftyDayAverage": 4.0535, "twoHundredDayAverage": 4.47715, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14243949, "profitMargins": 0.0, "floatShares": 4236627, "sharesOutstanding": 4245710, "sharesShort": 314455, "sharesShortPriorMonth": 223744, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.074099995, "heldPercentInsiders": 0.02398, "heldPercentInstitutions": 0.03217, "shortRatio": 1.33, "shortPercentOfFloat": 0.076, "impliedSharesOutstanding": 4245710, "bookValue": 1.55, "priceToBook": 2.7096775, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -16375951, "trailingEps": -4.03, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.904, "52WeekChange": -0.47761196, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 4.2, "targetHighPrice": 61.0, "targetLowPrice": 8.0, "targetMeanPrice": 29.0, "targetMedianPrice": 20.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 9518966, "totalCashPerShare": 2.242, "ebitda": -15748010, "totalDebt": 5081778, "quickRatio": 1.71, "currentRatio": 1.871, "debtToEquity": 85.684, "returnOnAssets": -1.14136, "returnOnEquity": -3.5806398, "grossProfits": -9860906, "freeCashflow": -8310179, "operatingCashflow": -14313309, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "postMarketChangePercent": -0.238089, "postMarketPrice": 4.19, "postMarketChange": -0.00999975, "regularMarketChange": -0.16140032, "regularMarketDayRange": "4.15 - 4.46", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 146979, "fiftyTwoWeekLowChange": 2.3999999, "fiftyTwoWeekLowChangePercent": 1.3333333, "fiftyTwoWeekRange": "1.8 - 20.83", "fiftyTwoWeekHighChange": -16.630001, "fiftyTwoWeekHighChangePercent": -0.7983678, "fiftyTwoWeekChangePercent": -47.761196, "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1749857895, "regularMarketTime": 1749844800, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.7006538, "regularMarketPrice": 4.2, "epsTrailingTwelveMonths": -4.03, "epsForward": -7.31, "epsCurrentYear": -3.045, "priceEpsCurrentYear": -1.3793103, "fiftyDayAverageChange": 0.14649963, "fiftyDayAverageChangePercent": 0.036141515, "twoHundredDayAverageChange": -0.27715015, "twoHundredDayAverageChangePercent": -0.061903253, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "cryptoTradeable": false, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]